Share Option Scheme - As of June 30, 2023, the total number of shares available for grant under the 2013 Share Option Scheme was 48,916,830 shares, which has now been reduced to nil shares following the expiration of the scheme[20]. - The Group currently has no plans to adopt any new Share Option Scheme following the termination of the 2013 Share Option Scheme[20]. - No share options were granted under the 2013 Share Option Scheme since its adoption[21]. - The Group had no other share scheme in force at the end of the reporting period[20]. Financial Performance - For the six months ended June 30, 2023, the Group recorded revenue of approximately HKD 76,144,000, a decrease of about 87% compared to HKD 573,831,000 for the same period in 2022[58]. - Gross profit for the same period was approximately HKD 673,000, down 96% from HKD 17,624,000 in 2022[58]. - Net profit for the period was approximately HKD 8,330,000, down from HKD 18,079,000 in 2022[58]. - The Group's profit for the Period was approximately HK$8,330,000, a decrease of approximately 54% compared to HK$18,079,000 in the 2022 Period[115]. - Profit before taxation was HK$8,330,000, a decrease of 63.24% from HK$22,602,000 in the previous year[168]. - Profit attributable to owners of the Company for the period was HK$8,330,000, compared to HK$18,079,000 in 2022, indicating a decline of 54.00%[168]. - Basic and diluted earnings per share were HK1.70 cents, down from HK3.70 cents in the same period last year[168]. Sales and Production - The Group completed sales of approximately 200,000 pounds of natural uranium products, significantly lower than approximately 1,600,000 pounds in the previous year[58]. - Sales volume of natural uranium products decreased to approximately 0.2 million pounds in the current period from approximately 1.6 million pounds in the 2022 Period[82]. - The Group has contracted approximately 0.8 million pounds of natural uranium products, expected to generate approximately 2% commission income upon completion in the second half of 2023[90]. - The Group has a pending contract for approximately 800,000 pounds of natural uranium products, expected to generate about 2% commission income upon completion in the second half of 2023[122]. Financial Position - Current assets decreased by approximately 5% to HK$197,993,000, primarily due to reduced cash and cash equivalents[95]. - Non-current assets increased by approximately 1% to HK$441,172,000, attributed to the share of results from an associate[95]. - Total shareholders' funds decreased from approximately HK$391,608,000 to HK$378,923,000, with a gearing ratio increase to approximately 0.41[96]. - Current liabilities as of June 30, 2023, amounted to approximately HK$78,242,000, representing a 7% increase from approximately HK$73,318,000 as of December 31, 2022[126]. - The Group's net cash outflow was approximately HK$53,993,000 during the period, compared to HK$21,005,000 in the previous period[95]. - The Group's total comprehensive expense for the Period was approximately HK$12,685,000, compared to an income of approximately HK$9,830,000 in the 2022 Period[116]. Market Conditions - The spot price of natural uranium fluctuated between USD 48 and USD 57.75 per pound during the review period, with a closing price of approximately USD 56 per pound[59]. - Long-term natural uranium contract prices increased from USD 51 per pound to approximately USD 56 per pound by the end of the period[59]. Corporate Governance - The Company has established a Remuneration Committee to review the remuneration policy and structure for directors and senior management[165]. - The Nomination Committee has been formed to assess the structure, size, and composition of the Board, and to recommend changes as necessary[165]. - The Audit Committee consists of three independent non-executive Directors and one non-executive Director, ensuring independent communication with management and external auditors[146]. - The Company has complied with all relevant codes and standards regarding securities transactions by directors[145]. Investments and Acquisitions - The Group has not made any material acquisitions or disposals of subsidiaries during the period[97]. - The Group's significant investment in Somina, holding 37.2% of its equity, has been pledged to a bank for financing purposes[159]. - The Group has no significant investments or capital asset plans as of June 30, 2023[143]. - As of June 30, 2023, the Group did not have plans for material investments and capital assets[161]. Shareholder Matters - The Group did not recommend the payment of an interim dividend for the Period, consistent with the 2022 Period[107]. - The Board expresses appreciation to shareholders, management, and staff for their dedication and support[149].
中核国际(02302) - 2023 - 中期财报